Product Information
Product Information
JiviTM (antihemophilic factor (recombinant) PEGylated-aucl
JIVI, antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age and older) with hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.
JIVI is not indicated for: use in children less than 12 years of age due to a greater risk for hypersensitivity reactions, use in previously untreated patients (PUPs), or for the treatment of von Willebrand disease.
Kovaltry® (antihemophilic factor, recombinant)
KOVALTRY, Antihemophilic Factor (Recombinant), is a recombinant, human DNA sequence derived, full length Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.
KOVALTRY is not indicated for the treatment of von Willebrand disease.
Follow Us
